The estimated Net Worth of Roman Trawicki is at least $13.1 Milion dollars as of 16 March 2022. Mr Trawicki owns over 6,000 units of Zoetis Inc stock worth over $2,701,278 and over the last 9 years he sold ZTS stock worth over $8,255,444. In addition, he makes $2,190,450 as Exec. VP and Pres of Global Manufacturing & Supply at Zoetis Inc.
Sign up
Mr Trawicki ZTS stock SEC Form 4 insiders trading
Mr has made over 19 trades of the Zoetis Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 6,000 units of ZTS stock worth $525,060 on 16 March 2022.
The largest trade he's ever made was exercising 23,885 units of Zoetis Inc stock on 23 February 2018 worth over $1,020,606. On average, Mr trades about 4,707 units every 46 days since 2015. As of 16 March 2022 he still owns at least 14,218 units of Zoetis Inc stock.
You can see the complete history of Mr Trawicki stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Roman Trawicki biography
Roman Trawicki is the Exec. VP and Pres of Global Manufacturing & Supply at Zoetis Inc.
What is the salary of Mr Trawicki?
As the Exec. VP and Pres of Global Manufacturing & Supply of Zoetis Inc, the total compensation of Mr Trawicki at Zoetis Inc is $2,190,450. There are 5 executives at Zoetis Inc getting paid more, with Glenn David having the highest compensation of $3,672,350.
How old is Mr Trawicki?
Mr Trawicki is 57, he's been the Exec. VP and Pres of Global Manufacturing & Supply of Zoetis Inc since . There are 11 older and 12 younger executives at Zoetis Inc. The oldest executive at Zoetis Inc is William Steere, 83, who is the Independent Director.
What's Mr Trawicki's mailing address?
Roman's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.
Insiders trading at Zoetis Inc
Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio oraz Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.
What does Zoetis Inc do?
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
What does Zoetis Inc's logo look like?
Complete history of Mr Trawicki stock trades at Zoetis Inc
Zoetis Inc executives and stock owners
Zoetis Inc executives and other stock owners filed with the SEC include:
-
Glenn David,
Chief Financial Officer, Executive Vice President -
Kristin Peck,
Chief Executive Officer, Director -
Catherine Knupp,
Executive Vice President, President - Research and Development -
Kristin C. Peck,
CEO & Director -
Wafaa Mamilli,
Exec. VP and Chief Information & Digital Officer -
Roman Trawicki,
Exec. VP and Pres of Global Manufacturing & Supply -
Glenn C. David,
Exec. VP and Group Pres of International Operations, Aquaculture, BioDevices & Pet Insurance -
Michael McCallister,
Non-Executive Independent Chairman of the Board -
Robert Scully,
Independent Director -
Gregory Norden,
Independent Director -
Paul Bisaro,
Independent Director -
William Steere,
Independent Director -
Linda Rhodes,
Independent Director -
Willie Reed,
Independent Director -
Louise Parent,
Independent Director -
Sanjay Khosla,
Independent Director -
Frank D'Amelio,
Independent Director -
Roman Trawicki,
Executive Vice President, President - Global Manufacturing and Supply -
Heidi Chen,
Executive Vice President, General Counsel, Corporate Secretary -
Roxanne Lagano,
Chief Human Resource Officer, Executive Vice President and Global Operations -
Heidi C. Chen,
Exec. VP, Gen. Counsel, Corp. Sec. & Bus. Lead of Human Health Diagnostics -
Roxanne Lagano,
Exec. VP and Chief HR Officer & Global Operations -
Wetteny N. Joseph,
Exec. VP & CFO -
Timothy J. Bettington,
Exec. VP and Pres of U.S. Operations & Global Customer Experience -
William Price,
VP & Chief Communications Officer -
Steven Frank,
VP of Investor Relations -
Gavin Hattersley,
Director -
Robert Edward Kelly,
Executive Vice President -
Alejandro Bernal,
Executive Vice President -
Juan Ramon Alaix,
Director -
Clinton A. Jr. Lewis,
Executive Vice President -
Sherry N Pudloski,
Executive Vice President -
Robert J Polzer,
Executive Vice President -
Amy W Schulman,
Director -
Sandra J. Beaty,
Executive Vice President -
Joyce J. Lee,
Executive Vice President -
Douglas E. Giordano,
Director -
William F Doyle,
-
Inc Pfizer,
Director -
Square Capital Management, ...,
-
Stefan Weiskopf,
Executive Vice President -
Richard A. Passov,
EVP, Chief Financial Officer -
Paul Herendeen,
Exec. V.P. and CFO -
Charles H Hill,
Director -
Geno J Germano,
Director -
Andrew Fenton,
Executive Vice President -
James Michael Mc Farland,
Executive Vice President -
Wafaa Mamilli,
Executive Vice President -
Timothy J Bettington,
Executive Vice President -
Antoinette Renee Leatherberry,
Director -
Astorga Jeannette Ferran,
Executive Vice President -
Abhay U Nayak,
Executive Vice President -
Wetteny Joseph,
Chief Financial Officer -
Rimma Driscoll,
Executive Vice President -
Vanessa Broadhurst,
Director -
Jamie Brannan,
Executive Vice President -
Nicholas Ashton,
Executive Vice President -
Soria Ester Banque,
Executive Vice President